In controlled laboratory settings, receptor sensitivity may vary depending on study duration, concentration, and protocol design
The efficacy of semaglutide in promoting weight loss has been demonstrated in multiple clinical trials
It belongs to a class of medications called dual GIP and GLP-1 receptor agonists , which means it mimics the effects of two natural hormones involved in managing appetite, insulin secretion, and glucose metabolism
For individuals managing type 2 diabetes, Semaglutide is often combined with other diabetes medications such as metformin, SGLT2 inhibitors, or insulin, depending on the patients needs and medical history
A Diabetes-Specific Approach At the height of semaglutide shortages in 2023, experts from the American Diabetes Association published recommendations around how to prescribe lower doses for patients with diabetes